Lotrel amlodipine/benazepril: Interim Phase III data

In the U.S. and Scandinavian Phase III ACCOMPLISH trial in >11,000 patients, Lotrel reduced cardiovascular morbidity and mortality by 20% vs. a combination benazepril/hydrochlorothiazide pill. Also, 8...